AKARI Therapeutics Company

Akari is developing inhibitors of acute and chronic inflammation, specifically the complement and leukotriene systems, to treat rare and orphan diseases with unmet need.


Connections from

Technology: Scientifically-Validated Lifestyle Recommendation
Headquarters: United States
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: 2005
Industry: Stem Cell Exhaustion
Employee Number: 11-50
Investor Type: N/A
Funding Status: IPO